Literature DB >> 10919427

The effect of humidification and smoking habit on the incidence of adverse airway events during deepening of anaesthesia with desflurane.

A R Wilkes1, J E Hall, E Wright, S Grundler.   

Abstract

The effect of two levels of humidification on the incidence of adverse airway events was studied in 58 adult female patients during deepening of anaesthesia using up to 12% desflurane. Humidification was provided by a breathing system filter with either low moisture-conserving performance (17.2 mg x l(-1) at 0.5 1 tidal volume, Group L) or high moisture-conserving performance (33.5 mg x l(-1) at 0.5 1 tidal volume, Group H). Forty-eight per cent of patients smoked and there were more smokers in Group L than in Group H. Adverse airway events consisted of coughing and laryngospasm. For coughing, the dominant explanator was smoking. When both humidity and age were included in the analysis, there was a significant smoking-humidity interaction (p < 0.05), such that high humidity decreased the incidence of coughing in nonsmokers but not in smokers. The incidence of laryngospasm was significantly lower in Group H than in Group L (p < 0.05). We conclude that when patients inspire high concentrations of desflurane during induction of anaesthesia, increasing humidification to the levels achieved in this study decreases the incidence of coughing among nonsmokers and of laryngospasm in both smokers and nonsmokers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919427     DOI: 10.1046/j.1365-2044.2000.01469.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Desflurane requirements for laryngeal mask airway insertion during inhalation induction.

Authors:  Hwa-Yong Shin; Jung-Ae Lim; Seong-Hyop Kim; Seung-Woo Baek; Duk-Kyung Kim
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

Review 2.  Tobacco control for anesthesiologists.

Authors:  David O Warner
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.